# Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease

> **NCT00962260** · — · NO_LONGER_AVAILABLE · sponsor: **Pfizer**

## Conditions studied

- Gaucher Disease

## Interventions

- **DRUG:** Plant cell expressed recombinant glucocerebrosidase (prGCD)

## Key facts

- **NCT ID:** NCT00962260
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962260, "Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00962260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*